🇺🇸 FDA
Patent

US 7960383

Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors

granted A61PA61P1/00A61P1/04

Quick answer

US patent 7960383 (Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors) held by Laboratories Almirall, S.A. expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Laboratories Almirall, S.A.
Grant date
Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P1/00, A61P1/04, A61P11/00, A61P11/02